Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Clinical trial NCT05422092 · UNKNOWN

Trial details

NCT number

NCT05422092

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Status

UNKNOWN

Phase

Not Applicable

Study type

INTERVENTIONAL

Start date

2022-09-20

Primary completion

2023-01-01

Enrollment

80

View on ClinicalTrials.gov